- Clinical Trials
- October 2020
- 108 Pages
Global
From €2413EUR$2,500USD£2,070GBP
- Report
- June 2018
- 49 Pages
Global
From €3373EUR$3,495USD£2,894GBP
- Report
- February 2024
- 71 Pages
Global
From €3500EUR$3,884USD£3,107GBP
- Book
- May 2021
- 224 Pages
- Book
- November 2018
- 464 Pages
- Book
- September 2013
- 152 Pages
Retinitis is a condition that affects the retina, the light-sensitive tissue at the back of the eye. It is caused by a variety of factors, including genetic disorders, infections, and exposure to toxins. Symptoms of retinitis include blurred vision, difficulty seeing in dim light, and loss of peripheral vision. Treatment options include medications, laser therapy, and surgery.
Optical treatments for retinitis include corrective lenses, such as glasses and contact lenses, and low vision aids, such as magnifiers and telescopes. These treatments can help improve vision and reduce the risk of further vision loss.
The retinitis market is composed of companies that develop and manufacture products to treat retinitis. These products include medications, corrective lenses, and low vision aids. Companies in the retinitis market include Bausch + Lomb, Novartis, and Allergan. Show Less Read more